末梢神経刺激装置(PNS):医療機器パイプライン分析

◆英語タイトル:Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0141
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥525,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD7,500 ⇒換算¥787,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Peripheral Nerve Stimulators (PNS) – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Peripheral Nerve Stimulators (PNS) – Medical Devices Pipeline Assessment, 2019″ provides an overview of Peripheral Nerve Stimulators (PNS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Nerve Stimulators (PNS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Peripheral Nerve Stimulators (PNS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Peripheral Nerve Stimulators (PNS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Peripheral Nerve Stimulators (PNS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 Peripheral Nerve Stimulators (PNS) Overview 4
3 Products under Development 5
3.1 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Stage of Development 5
3.2 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Territory 6
3.3 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Regulatory Path 7
3.4 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Estimated Approval Date 8
3.5 Peripheral Nerve Stimulators (PNS) – Ongoing Clinical Trials 9
4 Peripheral Nerve Stimulators (PNS) – Pipeline Products under Development by Companies 10
4.1 Peripheral Nerve Stimulators (PNS) Companies – Pipeline Products by Stage of Development 10
4.2 Peripheral Nerve Stimulators (PNS) – Pipeline Products by Stage of Development 11
5 Peripheral Nerve Stimulators (PNS) Companies and Product Overview 12
5.1 Actuated Medical Inc Company Overview 12
5.1.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 12
5.2 Cardionomic Inc (Inactive) Company Overview 13
5.2.1 Cardionomic Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 13
5.3 Checkpoint Surgical Inc Company Overview 14
5.3.1 Checkpoint Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.4 EMKinetics, Inc. Company Overview 15
5.4.1 EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
5.5 Epineuron Technologies Inc Company Overview 18
5.5.1 Epineuron Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.6 Gondola Medical Technologies SA Company Overview 19
5.6.1 Gondola Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 19
5.7 Remedee Labs SAS Company Overview 22
5.7.1 Remedee Labs SAS Pipeline Products & Ongoing Clinical Trials Overview 22
5.8 Washington University School of Medicine Company Overview 25
5.8.1 Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 25
6 Peripheral Nerve Stimulators (PNS)- Recent Developments 26
6.1 Nov 13, 2019: Remedee Labs Breakthrough Endorphin Stimulation Solution Is Unveiled 26
6.2 Nov 13, 2019: New clinical trial into pain management started by leading French research hospital 26
6.3 Sep 23, 2019: Cala Health announces positive topline data from landmark PROSPECT study for essential tremor (ET) 26
6.4 Aug 21, 2019: SPR Therapeutics SPRINT Peripheral Nerve Stimulation System significantly reduces opioid use in patients with low back pain, interim data show 27
6.5 Apr 08, 2019: Study of SPR Therapeutics Peripheral Nerve Stimulation System demonstrates significant and sustained relief of post-amputation pain 28
6.6 Jan 17, 2019: Cala Health enrolls first patients in landmark PROSPECT study for essential tremor 29
6.7 Jan 15, 2019: SPR Therapeutics names Dr. Peter Staats as Chief Medical Advisor 30
7 Appendix 31
7.1 Methodology 31
7.2 About GlobalData 34
7.3 Contact Us 34
7.4 Disclaimer 34

List of Tables
Table 1: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development 5
Table 2: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory 6
Table 3: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path 7
Table 4: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date 8
Table 5: Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials 9
Table 6: Peripheral Nerve Stimulators (PNS) Companies - Pipeline Products by Stage of Development 10
Table 7: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development 11
Table 8: Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 12
Table 9: Peripheral Nerve Targeting System - Product Status 12
Table 10: Peripheral Nerve Targeting System - Product Description 12
Table 11: Cardionomic Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 13
Table 12: Neurostimulator - Cardiac Contractility - Product Status 13
Table 13: Neurostimulator - Cardiac Contractility - Product Description 13
Table 14: Checkpoint Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 14
Table 15: Checkpoint BEST System - Product Status 14
Table 16: Checkpoint BEST System - Product Description 14
Table 17: EMKinetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 18: TranStim Transdermal Neuromodulation System - Product Status 15
Table 19: TranStim Transdermal Neuromodulation System - Product Description 15
Table 20: EMKinetics, Inc. - Ongoing Clinical Trials Overview 16
Table 21: TranStim Transdermal Neuromodulation System - Posterior Tibial Nerve Stimulation's Effectiveness in UI Frequency in Overactive Patients in Home 17
Table 22: Epineuron Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 18
Table 23: Wearable Device - Peripheral Nerve Stimulation - Product Status 18
Table 24: Wearable Device - Peripheral Nerve Stimulation - Product Description 18
Table 25: Gondola Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 19
Table 26: Gondola Device - Product Status 19
Table 27: Gondola Device - Product Description 19
Table 28: Gondola Medical Technologies SA - Ongoing Clinical Trials Overview 20
Table 29: Gondola Device - Multi-center, Double-blind, Cross-over Randomized Study on the Use of the Medical Device Gondola for Motor Rehabilitation in Patients with Parkinson's Disease 21
Table 30: Remedee Labs SAS Pipeline Products & Ongoing Clinical Trials Overview 22
Table 31: Endorphin-Stimulation Device - Product Status 22
Table 32: Endorphin-Stimulation Device - Product Description 22
Table 33: Remedee Labs SAS - Ongoing Clinical Trials Overview 23
Table 34: Endorphin-Stimulation Device - Innovative Device for Pain Management by Millimeter Band Radiation: Electronic-Pain Killer: First in Human Evaluation in Perioperative with Regard to a Control Group 24
Table 35: Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 25
Table 36: Biodegradable Device - Electrical Stimulation - Product Status 25
Table 37: Biodegradable Device - Electrical Stimulation - Product Description 25
Table 38: Glossary 33

List of Figures
Figure 1: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Stage of Development 5
Figure 2: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Territory 6
Figure 3: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Regulatory Path 7
Figure 4: Peripheral Nerve Stimulators (PNS) - Pipeline Products by Estimated Approval Date 8
Figure 5: Peripheral Nerve Stimulators (PNS) - Ongoing Clinical Trials 9

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[末梢神経刺激装置(PNS):医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆